Ocular changes in patients undergoing long-term desferrioxamine treatment.

Ocular changes in patients undergoing long-term desferrioxamine treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Ocular changes in patients undergoing long-term desferrioxamine treatment. Abstract Text:

In a group of young patients with thalassaemia and iron overload treated by subcutaneous infusions of desferrioxamine we have found a number of minor alterations in retinal function. The incidence of such changes is not related to drug dosage or to ferritin level but to abnormality of the extended glucose tolerance test.

Ocular changes in patients undergoing long-term desferrioxamine treatment. Publishing Authors By Initials

For similar hemic and lymphatic diseases: hematologic diseases: anemia: anemia, hemolytic: anemia, hemolytic, congenital: thalassemia research abstracts see: hemic and lymphatic diseases: hematologic diseases: anemia: anemia, hemolytic: anemia, hemolytic, congenital: thalassemia research

PUBMED ID PMID:

MEDLINE DATE:

Ocular changes in patients undergoing long-term desferrioxamine treatment. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The British journal of ophthalmology

VOLUME: 68

Page Numbers: 873-7

Journal Abbreviation: Br J Ophthalmol

ISSN: 0007-1161

DAY: 28

MONTH: Dec

YEAR: 1984

Ocular changes in patients undergoing long-term desferrioxamine treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 421041

Ocular changes in patients undergoing long-term desferrioxamine treatment. Keywords Mesh Terms:

KEYWORDS: Thalassemia

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Ocular changes in patients undergoing long-term desferrioxamine treatment. Information

Substance Name: Deferoxamine

Registry Number: 70-51-9

Grant and Affiliation Information for Ocular changes in patients undergoing long-term desferrioxamine treatment.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Ophthalmol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Ocular changes in patients undergoing long-term desferrioxamine treatment Related Publications

• Current biotechnological approaches to the prevention of restenosis.
• Ocular changes in patients undergoing long-term desferrioxamine treatment.
• Oxygen dissociation curve in Eales's disease.